Robert Smith Denounces Ticketmaster's Dynamic Pricing Model

The Cure's frontman criticizes the ticketing industry, advocating for fair prices and transparency in concert ticket sales.

Robert Smith, lead singer of The Cure, has been vocal against Ticketmaster's dynamic pricing, labeling it a 'scam' driven by greed.
The band avoided dynamic pricing on their 2023 tour, opting for non-transferable tickets to prevent scalping and ensure affordability.
Smith's advocacy led to partial refunds for fans affected by high service fees during The Cure's recent tour.
He emphasizes the importance of fair pricing, arguing that lower ticket costs lead to happier fans who are more likely to return.
The Cure is set to release their first album in 16 years, 'Songs of a Lost World,' on November 1, 2024.